| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JAT.3437 |
| P8608 | Fatcat ID | release_6kiwro3wqndodcsq6mfa7yzx5i |
| P698 | PubMed publication ID | 28165137 |
| P50 | author | Lik Voon Kiew | Q56996062 |
| Lip Yong Chung | Q56996081 | ||
| María J. Vicent | Q40558248 | ||
| P2093 | author name string | See Ziau Hoe | |
| Hong Boon Lee | |||
| Nina Japundžić-Žigon | |||
| Hoay Yan Cheah | |||
| P2860 | cites work | Cardiac tissue slices with prolonged survival for in vitro drug safety screening | Q57098043 |
| Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer | Q57617165 | ||
| Bioanalytical strategies for in-vitro and in-vivo evaluation of the toxicity induced by metallic nanoparticles | Q58436578 | ||
| Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 | ||
| Molecular modeling in structural nano-toxicology: interactions of nano-particles with nano-machinery of cells | Q23918813 | ||
| Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers | Q23919501 | ||
| Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes | Q23921944 | ||
| A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome | Q24316980 | ||
| Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure | Q24634002 | ||
| Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats | Q24814460 | ||
| In silico toxicology: computational methods for the prediction of chemical toxicity | Q26749472 | ||
| Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening | Q27012652 | ||
| ZebraBeat: a flexible platform for the analysis of the cardiac rate in zebrafish embryos | Q27309211 | ||
| Nanoparticle-induced platelet aggregation and vascular thrombosis | Q28191813 | ||
| Cellular toxicity of carbon-based nanomaterials | Q28245679 | ||
| No time to lose--high throughput screening to assess nanomaterial safety | Q28383671 | ||
| Quantitative nanostructure-activity relationship modeling | Q28385022 | ||
| Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge | Q28385227 | ||
| Recent advances in particulate matter and nanoparticle toxicology: a review of the in vivo and in vitro studies | Q28385376 | ||
| Changes in cardiopulmonary function induced by nanoparticles | Q28389900 | ||
| Influence of particle size on persistence and clearance of aerosolized silver nanoparticles in the rat lung | Q28390486 | ||
| Toxicity and developmental defects of different sizes and shape nickel nanoparticles in zebrafish | Q28391074 | ||
| High content screening in zebrafish speeds up hazard ranking of transition metal oxide nanoparticles | Q28392583 | ||
| Physicochemical properties of nanomaterials: implication in associated toxic manifestations | Q28392831 | ||
| Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials | Q28394548 | ||
| Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems | Q28395046 | ||
| Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model | Q28396392 | ||
| Copper Oxide Nanoparticles Are Highly Toxic: A Comparison between Metal Oxide Nanoparticles and Carbon Nanotubes | Q28651579 | ||
| SILVER NANOPARTICLE INDUCED OXIDATIVE STRESS-DEPENDENT TOXICITY IN SPRAGUE-DAWLEY RATS | Q29248673 | ||
| Role of Physicochemical Properties in Nanoparticle Toxicity | Q29248830 | ||
| Animal models of human disease: zebrafish swim into view | Q29615723 | ||
| Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations | Q30584400 | ||
| Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials | Q44166854 | ||
| Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model. | Q44247671 | ||
| Drugs that induce repolarization abnormalities cause bradycardia in zebrafish | Q44365400 | ||
| Nitric oxide regulates c-fos expression in nucleus tractus solitarii induced by baroreceptor activation via cGMP-dependent protein kinase and cAMP response element-binding protein phosphorylation | Q44741490 | ||
| Baroreceptor reflex control of heart rate in rats studied by induced and autogenic changes in arterial pressure | Q45214805 | ||
| Superparamagnetic iron oxide polyacrylic acid coated γ-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. | Q45754823 | ||
| Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. | Q45899432 | ||
| Nanocarriers and the delivered drug: effect interference due to intravenous administration. | Q45922201 | ||
| Repeated assessment of cardiovascular and respiratory functions using combined telemetry and whole-body plethysmography in the rat. | Q45926012 | ||
| Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. | Q45963212 | ||
| The role of nanoparticle size in hemocompatibility. | Q46018270 | ||
| Nanotoxicity of TiO(2) nanoparticles to erythrocyte in vitro | Q46327420 | ||
| Effect of "helper lipid" on lipoplex electrostatics | Q46623989 | ||
| Human primary erythroid cells as a more sensitive alternative in vitro hematological model for nanotoxicity studies: Toxicological effects of silver nanoparticles | Q46681962 | ||
| Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods | Q47205852 | ||
| Validation of volume-pressure recording tail-cuff blood pressure measurements | Q47304414 | ||
| Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. | Q47392790 | ||
| Left ventricular pressure, contractility and dP/dt(max) in nonclinical drug safety assessment studies | Q47670204 | ||
| Time-dependent biodistribution, clearance and biocompatibility of magnetic fibrin nanoparticles: an in vivo study. | Q50214231 | ||
| A comprehensive toxicity study of zinc oxide nanoparticles versus their bulk in Wistar rats: Toxicity study of zinc oxide nanoparticles. | Q50261614 | ||
| Injected nanoparticles: the combination of experimental systems to assess cardiovascular adverse effects. | Q50801722 | ||
| Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats. | Q51406378 | ||
| Cardiovascular assessment in radiotelemetry-implanted pregnant rats. | Q51511419 | ||
| An improved method of electrode placement in configuration Lead II for the reliable ECG recording by telemetry in the conscious rat. | Q51575738 | ||
| Nano zerovalent iron particles induce pulmonary and cardiovascular toxicity in an in vitro human co-culture model. | Q51596330 | ||
| Biokinetic uptake and efflux of silver nanoparticles in Daphnia magna. | Q51620502 | ||
| Validation of a continuous baroreceptor reflex sensitivity index calculated from spontaneous fluctuations of blood pressure and pulse interval in rats. | Q52268081 | ||
| Development of silica-coated silver iodide nanoparticles and their biodistribution. | Q53133947 | ||
| Cardiac inflammation involving in PKCε or ERK1/2-activated NF-κB signalling pathway in mice following exposure to titanium dioxide nanoparticles. | Q55025732 | ||
| Evaluation criteria for the quality of published experimental data on nanomaterials and their usefulness for QSAR modelling | Q30710110 | ||
| Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques | Q33253628 | ||
| Long-term exposure to CdTe quantum dots causes functional impairments in live cells | Q33272119 | ||
| Noninvasive technique for measurement of heartbeat regularity in zebrafish (Danio rerio) embryos | Q33410667 | ||
| Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models | Q33475063 | ||
| Temporal sequence parameters in isodistributional surrogate data: model and exact expressions | Q33711102 | ||
| Tissue architecture: the ultimate regulator of breast epithelial function | Q34103375 | ||
| Interactions of hydroxyapatite with proteins and its toxicological effect to zebrafish embryos development | Q34234954 | ||
| Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations | Q34315976 | ||
| Influence of polyethylene glycol coating on biodistribution and toxicity of nanoscale graphene oxide in mice after intravenous injection | Q34391639 | ||
| Cell interactions with three-dimensional matrices | Q34858344 | ||
| Current state and perspectives of 3D-QSAR. | Q35018973 | ||
| Big physics, small doses: the use of AMS and PET in human microdosing of development drugs | Q35075780 | ||
| Invited Review: Aging and the cardiovascular system | Q35576631 | ||
| Organ slices for the evaluation of human drug toxicity | Q35937255 | ||
| Cardiac tissue slices: preparation, handling, and successful optical mapping | Q36000066 | ||
| A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research | Q36267289 | ||
| Toxicity of cationic lipids and cationic polymers in gene delivery | Q36532318 | ||
| Eosinophilic myocarditis: case series and review of literature | Q36676094 | ||
| Perturbational profiling of nanomaterial biologic activity | Q36677215 | ||
| Preclinical cardiovascular risk assessment in modern drug development | Q36757160 | ||
| Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro | Q36760929 | ||
| Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells. | Q36781382 | ||
| Vasopressin and oxytocin in control of the cardiovascular system | Q36798875 | ||
| Shape signatures: new descriptors for predicting cardiotoxicity in silico | Q37377888 | ||
| In vivo human time-exposure study of orally dosed commercial silver nanoparticles. | Q37423403 | ||
| Calcium signaling in platelets | Q37473529 | ||
| In silico vascular modeling for personalized nanoparticle delivery | Q37540497 | ||
| Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals | Q37694413 | ||
| Toxicity assessment of nanomaterials: methods and challenges | Q37774931 | ||
| Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. | Q37873387 | ||
| Zebrafish as a model to study cardiac development and human cardiac disease | Q37878169 | ||
| Analysis of platelet function: role of microfluidics and nanodevices | Q37949602 | ||
| From 3D cell culture to organs-on-chips | Q37950229 | ||
| Cryopreservation of precision-cut tissue slices | Q38056171 | ||
| The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology | Q38069009 | ||
| Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology | Q38105137 | ||
| Human-on-chip for therapy development and fundamental science | Q38184015 | ||
| Cardiovascular pressure measurement in safety assessment studies: technology requirements and potential errors | Q38220586 | ||
| Radionuclides in drug development | Q38258978 | ||
| Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions. | Q38495085 | ||
| Zebrafish as tools for drug discovery | Q38585048 | ||
| A review of toxicity studies of single-walled carbon nanotubes in laboratory animals | Q38653410 | ||
| Recent advances, and unresolved issues, in the application of computational modelling to the prediction of the biological effects of nanomaterials | Q38684997 | ||
| Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research | Q38691889 | ||
| Assessing biocompatibility of graphene oxide-based nanocarriers: A review | Q38731767 | ||
| 3D In Vitro Model for Breast Cancer Research Using Magnetic Levitation and Bioprinting Method | Q38798722 | ||
| The in vitro and in vivo toxicity of graphene quantum dots | Q39009972 | ||
| Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt | Q39388979 | ||
| Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation | Q39618217 | ||
| Acute respiratory and systemic toxicity of pulmonary exposure to rutile Fe-doped TiO(2) nanorods | Q39632409 | ||
| Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities | Q39925620 | ||
| Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. | Q40502979 | ||
| Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. | Q40667906 | ||
| Gene delivery mediated by cationic liposomes: from biophysical aspects to enhancement of transfection | Q40813285 | ||
| Cardiovascular and autonomic alterations in rats with Parkinsonism induced by 6-OHDA and treated with L-DOPA. | Q41285378 | ||
| Liposomes for use in gene delivery | Q42183122 | ||
| Surface properties dictate uptake, distribution, excretion, and toxicity of nanoparticles in fish | Q42264179 | ||
| Role of AHR2 in the expression of novel cytochrome P450 1 family genes, cell cycle genes, and morphological defects in developing zebra fish exposed to 3,3',4,4',5-pentachlorobiphenyl or 2,3,7,8-tetrachlorodibenzo-p-dioxin | Q42517288 | ||
| Participation of Fos protein at the nucleus tractus solitarius in inhibitory modulation of baroreceptor reflex response in the rat. | Q42552101 | ||
| Subchronic toxicity and cardiovascular responses in spontaneously hypertensive rats after exposure to multiwalled carbon nanotubes by intratracheal instillation. | Q42702909 | ||
| Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles | Q42732635 | ||
| Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles | Q42832960 | ||
| Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging | Q43128848 | ||
| Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles | Q43415971 | ||
| Differential effects of the mixed ET(A)/ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release. | Q43506529 | ||
| Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease | Q43808885 | ||
| Cardiac autonomic regulation after lung exposure to carbon nanotubes | Q43895979 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1268-1285 | |
| P577 | publication date | 2017-02-06 | |
| P1433 | published in | Journal of Applied Toxicology | Q3186896 |
| P1476 | title | Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry | |
| P478 | volume | 37 |
Search more.